Sartorius AG (SOAGY)
57.43
+0.21
(+0.37%)
USD |
OTCM |
Aug 25, 16:00
Sartorius Enterprise Value : 15.64B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 15.64B |
| August 24, 2026 | 15.60B |
| August 21, 2026 | 15.82B |
| August 20, 2026 | 15.82B |
| August 19, 2026 | 15.23B |
| August 18, 2026 | 14.89B |
| August 17, 2026 | 15.05B |
| August 14, 2026 | 15.19B |
| August 13, 2026 | 15.21B |
| August 12, 2026 | 15.13B |
| August 11, 2026 | 15.23B |
| August 10, 2026 | 15.24B |
| August 07, 2026 | 15.10B |
| August 06, 2026 | 14.87B |
| August 05, 2026 | 14.85B |
| August 04, 2026 | 14.82B |
| August 03, 2026 | 14.82B |
| July 31, 2026 | 14.41B |
| July 30, 2026 | 14.59B |
| July 29, 2026 | 14.61B |
| July 28, 2026 | 14.49B |
| July 27, 2026 | 14.19B |
| July 24, 2026 | 14.33B |
| July 23, 2026 | 14.34B |
| July 22, 2026 | 14.45B |
| Date | Value |
|---|---|
| July 21, 2026 | 14.35B |
| July 20, 2026 | 15.01B |
| July 17, 2026 | 15.41B |
| July 16, 2026 | 15.38B |
| July 15, 2026 | 15.55B |
| July 14, 2026 | 15.62B |
| July 13, 2026 | 15.52B |
| July 10, 2026 | 15.29B |
| July 09, 2026 | 14.93B |
| July 08, 2026 | 14.44B |
| July 07, 2026 | 14.84B |
| July 06, 2026 | 14.81B |
| July 02, 2026 | 14.91B |
| July 01, 2026 | 14.74B |
| June 30, 2026 | 14.77B |
| June 29, 2026 | 14.50B |
| June 26, 2026 | 14.61B |
| June 25, 2026 | 14.70B |
| June 24, 2026 | 14.25B |
| June 23, 2026 | 14.06B |
| June 22, 2026 | 14.08B |
| June 18, 2026 | 14.31B |
| June 17, 2026 | 14.67B |
| June 16, 2026 | 14.88B |
| June 15, 2026 | 14.93B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Mesa Laboratories, Inc. | 843.28M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 2.607B |
| Agilent Technologies, Inc. | 45.23B |
| Bio-Rad Laboratories, Inc. | 10.19B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 107.78M |
| Revenue (Quarterly) | 1.060B |
| Total Expenses (Quarterly) | 983.54M |
| EPS Diluted (Quarterly) | 0.2219 |
| Gross Profit Margin (Quarterly) | 47.50% |
| Profit Margin (Quarterly) | 10.17% |
| Earnings Yield | 1.15% |
| Operating Earnings Yield | 3.72% |
| Normalized Earnings Yield | 1.388 |